Signaling pathways involving neurotransmitters could be altered in tumors and can re-entrain the cancer cell clock, thus integrating whole-body information into the cell’s circadian output; these systemic pathways might represent therapeutic targets to treat cancer, although the complex effect of these pathways on circadian reprogramming of cancer cells is still poorly understood. The gene discussed is CLOCK; the disease is cancer.